Two strengths of permethrin cream for treating scabies
Part of Infections, Skin clinical trials.
This trial compares two different strengths of permethrin cream, a standard treatment for scabies, to see if one works better or is safer. If you have scabies and are otherwise healthy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed scabies infection, meaning a doctor found mites or their eggs on your skin under a microscope.
- You must be between 2 and 85 years old.
- You must not have used any scabies treatment in the last 14 days.
- You cannot be pregnant or breastfeeding.
- You must not have a weakened immune system or be taking certain immune-suppressing medications.
- You cannot have had close contact with 5 or more people, or live in a long-term care facility where scabies could spread.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using a cream that kills scabies mites to find which works better for infants and young children. Your child might benefit from a more effective, easier way to get rid of the intense itching.
This study compares two common scabies treatments, permethrin cream and ivermectin pills, in children aged 6 to 15. The goal is to see which works better and is safer, which could help improve care for kids with scabies.
This study looks at how skin infections and bacteria in the nose affect people with scabies or atopic dermatitis. If you join, researchers will check your nasal bacteria and skin infection to better understand the link.
This study compares two prescription creams used to treat mild to moderate eczema (atopic dermatitis) in people aged 2 and older. The goal is to see which cream is safer and works better for reducing symptoms like itching and redness.
This study tests two different prescription creams, crisaborole and tacrolimus, to see which works better for treating eczema (also called atopic dermatitis) in people aged 5 to 25. If you or your child have mild to moderate eczema, this trial may help find a more effective treatment option.
This study compares two creams for treating mild to moderate eczema in children: crisaborole 2% and tacrolimus 0.1%. It aims to see which one is more effective and safe for your child.
Hear when a new Scabies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.